Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2005035498) USE OF NITROGENOUS BICYCLIC COMPOUND AS FEEDING CONTROL AGENT
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2005/035498 International Application No.: PCT/JP2004/015112
Publication Date: 21.04.2005 International Filing Date: 06.10.2004
IPC:
A61K 31/404 (2006.01) ,A61K 31/4045 (2006.01) ,A61K 31/4166 (2006.01) ,A61K 31/4178 (2006.01) ,A61K 31/4184 (2006.01) ,A61K 31/4439 (2006.01) ,A61K 31/454 (2006.01) ,A61K 31/4545 (2006.01) ,A61K 31/496 (2006.01) ,A61K 31/497 (2006.01) ,A61K 31/5377 (2006.01) ,A61K 31/55 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
40
having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
403
condensed with carbocyclic rings, e.g. carbazole
404
Indoles, e.g. pindolol
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
40
having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
403
condensed with carbocyclic rings, e.g. carbazole
404
Indoles, e.g. pindolol
4045
Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
41
having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
4164
1,3-Diazoles
4166
having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
41
having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
4164
1,3-Diazoles
4178
not condensed and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
41
having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
4164
1,3-Diazoles
4184
condensed with carbocyclic rings, e.g. benzimidazoles
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
44
Non-condensed pyridines; Hydrogenated derivatives thereof
4427
containing further heterocyclic ring systems
4439
containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
44
Non-condensed pyridines; Hydrogenated derivatives thereof
445
Non-condensed piperidines, e.g. piperocaine
4523
containing further heterocyclic ring systems
454
containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
44
Non-condensed pyridines; Hydrogenated derivatives thereof
445
Non-condensed piperidines, e.g. piperocaine
4523
containing further heterocyclic ring systems
4545
containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
495
having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
496
Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
495
having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
4965
Non-condensed pyrazines
497
containing further heterocyclic rings
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
535
having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
5375
1,4-Oxazines, e.g. morpholine
5377
not condensed and containing further heterocyclic rings, e.g. timolol
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
55
having seven-membered rings, e.g. azelastine, pentylenetetrazole
Applicants:
DAINIPPON SUMITOMO PHARMA CO., LTD. [JP/JP]; 6-8, Dosho-machi 2-chome, Chuo-ku Osaka-shi, Osaka 5418524, JP (AllExceptUS)
永田 龍 NAGATA, Ryu [JP/JP]; JP (UsOnly)
徳永 輝久 TOKUNAGA, Teruhisa [JP/JP]; JP (UsOnly)
髙崎 毅 TAKASAKI, Tsuyoshi [JP/JP]; JP (UsOnly)
長嶺 純 NAGAMINE, Jun [JP/JP]; JP (UsOnly)
泰地 睦夫 TAIJI, Mutsuo [JP/JP]; JP (UsOnly)
Inventors:
永田 龍 NAGATA, Ryu; JP
徳永 輝久 TOKUNAGA, Teruhisa; JP
髙崎 毅 TAKASAKI, Tsuyoshi; JP
長嶺 純 NAGAMINE, Jun; JP
泰地 睦夫 TAIJI, Mutsuo; JP
Agent:
五十部 穣 ISOBE, Yutaka; 〒5540022 大阪府大阪市此花区春日出中3丁目1番98号 住友製薬株式会社 知的財産部内 Osaka Intellectual Property (Kasugade), Dainippon Sumitomo Pharma Co., Ltd. 1-98, Kasugadenaka 3-chome Konohana-ku, Osaka-shi Osaka 5540022, JP
Priority Data:
2003-34894008.10.2003JP
Title (EN) USE OF NITROGENOUS BICYCLIC COMPOUND AS FEEDING CONTROL AGENT
(FR) UTILISATION D'UN COMPOSE BICYCLIQUE AZOTE COMME AGENT DE REGULATION ALIMENTAIRE
(JA) 含窒素二環性化合物の摂食調節剤としての用途
Abstract:
(EN) Use of a compound represented by the following formula (1), a prodrug thereof, or a pharmaceutically acceptable salt of either as a feeding control agent useful as a therapeutic, preventive, or ameliorating agent for diabetic diseases, etc. (1) [In the formula, R1, R2, R3, and R4 each independently represents hydrogen, optionally substituted alkyl, etc.; R5 represents optionally substituted aryl, etc.; X represents nitrogen, etc.; and W1 represents the formula (2): wherein n is 0, 1, 2, or 3; m is 0, 1, 2, or 3; R7 and R8 each independently represents hydrogen, etc.; and R9 and R10 each independently represents optionally substituted alkyl, etc.]
(FR) L'invention concerne l'utilisation d'un composé représenté par la formule (1) suivante, un promédicament de celui-ci, ou un sel pharmaceutiquement acceptable d'un agent de régulation alimentaire servant d'agent thérapeutique, prophylactique ou améliorant de maladies diabétiques, etc. [Dans cette formule, R1, R2, R3, et R4 représentent chacun indépendamment hydrogène, alkyle éventuellement substitué, etc.; R5 représente aryle éventuellement substitué, etc.; X représente azote, etc.; et W1 représente la formule (2), dans laquelle n est égal à 1, 2, ou 3; m est égal à 0, 1, 2, ou 3; R7 et R8 représentent chacun indépendamment hydrogène, etc.; et R9 et R10 représentent chacun indépendamment alkyle éventuellement substitué, etc.]
(JA) not available
front page image
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)